期刊
OBSTETRICAL & GYNECOLOGICAL SURVEY
卷 64, 期 10, 页码 673-680出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/OGX.0b013e3181b8aff3
关键词
-
资金
- Department of Pathology, University of North Carolina at Chapel Hill
Carcinosarcoma of the ovary, also referred to as mixed mullerian tumor of the ovary, is a rare and aggressive tumor. This tumor type is unique in that it contains malignant epithelial and stromal elements. The average survival for a woman diagnosed with carcinosarcoma of the ovary is less than 2 years. Due to the rarity of this tumor, the optimal treatment for carcinosarcoma of the ovary has not been determined. We review the pathology, risk factors, and current treatment recommendations for carcinosarcoma of the ovary. Target Audience: Obstetricians & Gynecologists, Family Physicians Learning Objectives: After completion of this educational activity, the participant should be better able to recall the existence of carcinosarcoma of the ovary, demonstrate that with rare tumors, analogous treatment regimens are used, and plan to refer patients with carcinosarcoma of the ovary to gynecologic oncologist for treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据